Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Leading Edge Materials' Investor Update and Significant Activities (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dri Healthcare Trust
T.DHT.UN
Alternate Symbol(s):
DHTRF
Healthcare
Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio...
includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:DHT.UN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(82)
•••
BlueJay2020
X
Post by
BlueJay2020
on Aug 14, 2024 1:22pm
$13.XX broached!
Nice to see. I've also managed to get my holding up to 1500 shares and will continue to accumulate here. This cannot and will not stay around $13. Smart money will move in and snap
...more
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Aug 13, 2024 11:38am
RE:SP Recovery...
Indeed. My bet is that the drop-off in volume will give us small daily gains powered by the constant NCIB buying pressure. Once we get to $13, the chartists and momentum players will jump in and the
...more
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Aug 13, 2024 10:02am
RE:So far so good!
Oops again. NCIB can't run at open or after 3:30.
(7)
•••
sunshine7
X
Post by
sunshine7
on Aug 13, 2024 9:15am
SP Recovery...
Actually I am surprised that share price is not recovering faster now that risk is resolved.
(6300)
•••
retiredcf
X
Post by
retiredcf
on Aug 13, 2024 9:13am
Stifel
Stifel analyst Justin Keywood expects continued market volatility in the North American pharmaceuticals sector, pointing to “macro uncertainty as the U.S. election approaches.” “We see a general
...more
(82)
•••
BlueJay2020
X
Post by
BlueJay2020
on Aug 12, 2024 6:50pm
CIBCAsset Management are buyers!
While some investors are analyzing economic data and the U.S. presidential race to determine which stocks to buy and sell right now, money manager Craig Jerusalim remains focused on longer-term
...more
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Aug 12, 2024 5:06pm
RE:So far so good!
Oops, 14k+ under the NCIB. Imagine the price move if sellers dry up! Note that NCIB purchases can only happen on the last traded price, so if you're looking to accumulate buy a board lot at
...more
(70)
•••
SONOFFERGUS
X
Post by
SONOFFERGUS
on Aug 12, 2024 5:02pm
So far so good!
Volume 28k versus 70k Friday. Closed on high. Note that NCIB can't buy after 3:45. This is very positive -- most days post-crisis there has been a hard sell-off at close, indicating a
...more
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Aug 12, 2024 7:39am
RE:RE:RE:RE:RE:Scotia raises target to US$21
Noice. July report of insider trading shows NCIB at work every day, with lots of days buying the TSX daily maximum of 14,784 units and high daily average buy at $12.48. IMHO, sellers
...more
(6300)
•••
retiredcf
X
Post by
retiredcf
on Aug 11, 2024 1:45pm
RBC
Their upside scenario target is $19.00. GLTA August 7, 2024 Outperform TSX: DHT-U; CAD 12.04 Price Target CAD 16.00
...more
(6300)
•••
retiredcf
X
Post by
retiredcf
on Aug 11, 2024 8:10am
Raymond James
Seems reasonable. GLTA Dri Healthcare Trust : Raymond James cuts target price to C$20 from C$24
(82)
•••
BlueJay2020
X
Comment by
BlueJay2020
on Aug 09, 2024 1:42pm
RE:RE:RE:RE:Scotia raises target to US$21
Slowly scraping a position together - now holding 1100 at $12,10 average. Small beer, really!
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Aug 09, 2024 12:24pm
RE:RE:RE:Scotia raises target to US$21
Most analysts are wusses, adjusting their PTs after Mr. Market decides. Stifel guy seems like one of those. Even his PT gives pretty good upside tho, as bluejay2020 points out. Did you
...more
(82)
•••
BlueJay2020
X
Comment by
BlueJay2020
on Aug 09, 2024 11:12am
RE:RE:RE:Scotia raises target to US$21
OK, let's take the average of the other two, which is $16.25. Significant upside!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Have you held units of a TD mutual fund through a discount broker? Learn more.
ReGen III: Pioneering a Cleaner Lubricants Future with Patented Re-Refining